3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. (Q33540473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

G B Baker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Bourin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

Neuroscience & Biobehavioral Reviews

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

539-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; "EVE").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Ecstacy: a review of MDMA and MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The Clandestine Drug Laboratory Situation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Effects of MDMA on complex brain function in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Further investigation of the discriminative stimulus properties of MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Neuroendocrine and cardiovascular effects of MDE in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Subjective reports of the effects of MDMA in a clinical setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Can drugs be used to enhance the psychotherapeutic process?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The action of some amines related to adrenaline: methoxy-phenylisopropylamines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Ecstasy and the dance of death

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Two very different fatal cases associated with the use of methylenedioxyethylamphetamine (MDEA): Eve as deadly as Adam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Methamphetamine-induced neurotoxicity: structure activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Comparison of conditioned taste aversions produced by MDMA and d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

3,4-methylenedioxyamphetamine (MDA) self-administration and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Cerebral oedema after ingestion of MDMA ("ecstasy") and unrestricted intake of water

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

MDMA ("ecstasy") and panic disorder: induction by a single dose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Drinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Ecstasy and neurodegeneration. Advice is that "less is more".

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Pathology of deaths associated with "ecstasy" and "eve" misuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

MDMA (Ecstasy) precipitation of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A fatal case involving methylenedioxyamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Enhanced learning following a single, acute dose of MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

MDMA (ecstasy) and the rave: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Psychiatric complications of 'Ecstasy' use

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A pure amnestic syndrome after MDMA ("ecstasy") ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Death after ecstasy ingestion: neuropathological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Ecstasy and dantrolene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The properties of 3,4-methylenedioxyamphetamine (MDA). I. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Hyponatraemia must be treated with low water input

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Chronic paranoid psychosis after misuse of MDMA

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

Hydroxyl radical-mediated oxidation of serotonin: potential insights into the neurotoxicity of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2898%2900046-3

7 January 2021

10.1016/S0149-7634(98)00046-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10073892%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference